Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
Public ClinicalTrials.gov record NCT03126760. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of Acthar® in Subjects With Relapsing-remitting Multiple Sclerosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group. Each person has an equal chance of being in either one of two groups (like flipping a coin). One group will receive a shot of study medicine (called Acthar Gel) under their skin every day for 14 days. The other group will receive a shot every day for 14 days, too, but there is no medicine in it (called placebo).
Study identification
- NCT ID
- NCT03126760
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 35 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 22, 2017 (Actual)
- Primary completion
- Jul 14, 2020 (Actual)
- Completion
- Jul 14, 2020 (Actual)
- Last update posted
- Jul 12, 2021
2017 – 2020
United States locations
- U.S. sites
- 22
- U.S. states
- 14
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University Medical Center | Palo Alto | California | 94304 | — |
| Advanced Neurosciences Research LLC | Fort Collins | Colorado | 80528 | — |
| University of South Florida | Bradenton | Florida | 34205 | — |
| Neurology Associates, P. A. | Maitland | Florida | 32751 | — |
| University of Miami - Miller School of Medicine | Miami | Florida | 33136 | — |
| Tallahassee Neurological Clinic, PA | Tallahassee | Florida | 32308 | — |
| Multiple Sclerosis Center of Atlanta | Atlanta | Georgia | 30327 | — |
| Meridian Clinical Research LLC | Savannah | Georgia | 31405 | — |
| Consultants in Neurology LTD | Northbrook | Illinois | 60062 | — |
| OSF Healthcare System Saint Francis Medical Center | Peoria | Illinois | 61603 | — |
| Fort Wayne Neurological Center | Fort Wayne | Indiana | 46804 | — |
| University of Kansas Medical Center Research Institute, Inc. | Kansas City | Kansas | 66160 | — |
| Wayne State University (WSU) - Multiple Sclerosis Treatment and Clinical Research Center (MS Center) | Detroit | Michigan | 97205 | — |
| University of New Mexico | Albuquerque | New Mexico | 87131 | — |
| University of Buffalo | Buffalo | New York | 14215 | — |
| Wake Forest University School of Medicine | Winston-Salem | North Carolina | 27157 | — |
| The Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| University of Cincinnati Physicians Company, LLC | Dayton | Ohio | 45417 | — |
| Northern Ohio Neuroscience, LLC | Sandusky | Ohio | 44870 | — |
| Texas Neurology, PA | Dallas | Texas | 75214 | — |
| Neurology Center of San Antonio | San Antonio | Texas | 78258 | — |
| MultiCare Neuroscience Center of WA | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03126760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 12, 2021 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03126760 live on ClinicalTrials.gov.